EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Sleep in neurodegenerative diseases: A focus on melatonin, melanin‐concentrating hormone and orexin

Simon J Guillot iD, Pierre-Hervé Luppi iD, Luc Dupuis iD, Matei Bolborea iD

Journal of Neuroendocrinology · 2025

DOI: 10.1111/jne.70085 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neuroendocrinology, 2025. Verfasst von Simon J Guillot und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Strasbourg, INSERM, UMR-S 1329, Strasbourg Translational Neuroscience & Psychiatry, Strasbourg, France. Hauptthemen laut MEDLINE: Melanins, Orexins, Neurodegenerative Diseases, Melatonin. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 242 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, TargetALS, Fondation Thierry Latran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sleep and circadian rest‐activity rhythm alterations are recognised as inherent clinical features of various neurodegenerative diseases. Traditionally viewed as secondary manifestations of neurodegeneration, recent studies have revealed that disruptions in circadian rhythm and sleep–wake cycles can precede clinical symptoms and significantly contribute to the underlying pathophysiological progression. In this review, we summarise recent research on the impact of sleep and circadian rhythm alterations in ageing and major neurodegenerative diseases, including Alzheimer's, Parkinson's, Huntington's, amyotrophic lateral sclerosis, and frontotemporal dementia, highlighting the roles of melatonin, orexin, and melanin‐concentrating hormone (MCH) systems as key regulators at the intersection of sleep and neurodegeneration. We argue that sleep and circadian alterations may serve as early biomarkers and therapeutic targets for these diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelaninsOrexinsNeurodegenerative DiseasesMelatoninHypothalamic HormonesPituitary HormonesSleepHumansAnimalsCircadian Rhythm

Stichwörter der Autor:innen

circadian rhythmhypothalamusneurodegenerative diseasesleep

Substanzen

MelaninsOrexinsmelanin-concentrating hormoneMelatoninHypothalamic HormonesPituitary Hormones

Autor:innen und Institutionen

  • University of Strasbourg, INSERM, UMR-S 1329, Strasbourg Translational Neuroscience & Psychiatry, Strasbourg, France.
  • Centre of Neuroscience of Lyon, CNRS/INSERM, UMR 5292/UMR 1028, Lyon, France.

ORCID-Profile: Simon J Guillot, Pierre-Hervé Luppi, Luc Dupuis, Matei Bolborea

Förderung

  • Agence Nationale de la Recherche
  • TargetALS
  • Fondation Thierry Latran
  • Association Francaise de Recherche sur la sclérose latérale amyotrophique
  • Radala Foundation for ALS Research
  • ARSLA
  • University of Starsbourg fundation
  • Fondation Bettencourt Schueller

Zitieren

APA

Guillot, S. J., Luppi, P. H., Dupuis, L., & Bolborea, M. (2025). Sleep in neurodegenerative diseases: A focus on melatonin, melanin‐concentrating hormone and orexin. Journal of Neuroendocrinology. https://doi.org/10.1111/jne.70085

Vancouver

Guillot SJ, Luppi PH, Dupuis L, Bolborea M. Sleep in neurodegenerative diseases: A focus on melatonin, melanin‐concentrating hormone and orexin. Journal of Neuroendocrinology. 2025. doi:10.1111/jne.70085

BibTeX
@article{Guillot2025,
  author = {Guillot, Simon J and Luppi, Pierre-Hervé and Dupuis, Luc and Bolborea, Matei},
  title = {Sleep in neurodegenerative diseases: A focus on melatonin, melanin‐concentrating hormone and orexin},
  journal = {Journal of Neuroendocrinology},
  year = {2025},
  doi = {10.1111/jne.70085}
}
Kostenlos starten →